See also this year's filing and all EDGAR filings for this company.
PDF Report 0001411158_2013_Anacor_Pharmaceuticals_Inc.pdf
Logs
| error | Negative Expenses, ignoring company. | pre-agg | {'expenses': -69532000} |
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
| info | NetIncome node detected by revenue/expenses heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'OperatingIncomeLoss'} |
Graph
Absolute values for 0001411158, Anacor Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 49,293,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,516,000 |
| 3 | remainder_Assets | 262,000 |
| 4 | LiabilitiesCurrent | 25,391,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 11,614,000 |
| 9 | ResearchAndDevelopmentExpense | 52,318,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 10,740,000 |
| 12 | remainder_NetIncome | 0 |
| 13 | remainder_ComprehensiveNetIncome | -2,892,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 51,071,000 |
| 1 | Liabilities | 25,391,000 |
| 2 | Expenses | 63,932,000 |
| 3 | Revenues | 10,740,000 |
| 4 | StockholdersEquity | 25,680,000 |
| 5 | NetIncome | -53,192,000 |
| 6 | ComprehensiveNetIncome | -54,638,000 |
| 7 | BaseVar | 77,013,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.0352 |
| 9 | EconomicCapitalRatio | 1.45 |
Edgar->Model Mapping
Feature Distribution
Change over Time
